Sultana A, Banu L, Hossain M, Azmin N, Nila N, Sinha S
Viruses. 2025; 17(2).
PMID: 40006937
PMC: 11860708.
DOI: 10.3390/v17020182.
Jiang H, Li J, Zhang P, Huo X, Zhu F
Infect Dis Immun. 2024; 1(1):43-51.
PMID: 38630107
PMC: 8057314.
DOI: 10.1097/ID9.0000000000000003.
Caetano-Anolles K, Hernandez N, Mughal F, Tomaszewski T, Caetano-Anolles G
Methods Microbiol. 2024; 50:27-81.
PMID: 38620818
PMC: 8590929.
DOI: 10.1016/bs.mim.2021.10.002.
Hussein H, Thabet A, Wardany A, El-Adly A, Ali M, Hassan M
Virol J. 2024; 21(1):75.
PMID: 38539202
PMC: 10967059.
DOI: 10.1186/s12985-024-02342-w.
Jabeen M, Shoukat S, Shireen H, Bao Y, Khan A, Abbasi A
Virol J. 2024; 21(1):55.
PMID: 38449001
PMC: 10916261.
DOI: 10.1186/s12985-024-02328-8.
Frequency of SARS-CoV-2 variants identified by real-time PCR in the AUNA healthcare network, Peru.
Ortiz-Gomez T, Gomez A, Chuima B, Zevallos A, Ocampo K, Torres D
Front Public Health. 2024; 11:1244662.
PMID: 38410127
PMC: 10894931.
DOI: 10.3389/fpubh.2023.1244662.
Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses.
Rosas-Murrieta N, Rodriguez-Enriquez A, Herrera-Camacho I, Millan-Perez-Pena L, Santos-Lopez G, Rivera-Benitez J
Viruses. 2024; 16(2).
PMID: 38400014
PMC: 10892376.
DOI: 10.3390/v16020238.
The emergence of SARS-CoV-2 variants of concern in Australia by haplotype coalescence reveals a continental link to COVID-19 seasonality.
Tomaszewski T, Gurtler V, Caetano-Anolles K, Caetano-Anolles G
Methods Microbiol. 2023; 50:233-268.
PMID: 38013929
PMC: 9110064.
DOI: 10.1016/bs.mim.2022.03.003.
COV2Var, a function annotation database of SARS-CoV-2 genetic variation.
Feng Y, Yi J, Yang L, Wang Y, Wen J, Zhao W
Nucleic Acids Res. 2023; 52(D1):D701-D713.
PMID: 37897356
PMC: 10767816.
DOI: 10.1093/nar/gkad958.
Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles.
Alkhaldi S, Peng I, Peng C
Bioengineering (Basel). 2023; 10(6).
PMID: 37370582
PMC: 10294827.
DOI: 10.3390/bioengineering10060652.
In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants.
Haseeb M, Amir A, Ikram A
Vaccines (Basel). 2023; 11(4).
PMID: 37112648
PMC: 10145761.
DOI: 10.3390/vaccines11040736.
Seasonal effects decouple SARS-CoV-2 haplotypes worldwide.
Tomaszewski T, Ali M, Caetano-Anolles K, Caetano-Anolles G
F1000Res. 2023; 12:267.
PMID: 37069849
PMC: 10105261.
DOI: 10.12688/f1000research.131522.1.
A Protein Co-Conservation Network Model Characterizes Mutation Effects on SARS-CoV-2 Spike Protein.
Zeng L, Lu Y, Yan W, Yang Y
Int J Mol Sci. 2023; 24(4).
PMID: 36834664
PMC: 9960056.
DOI: 10.3390/ijms24043255.
Assessment of the longitudinal humoral response in non-hospitalized SARS-CoV-2-positive individuals at decentralized sites: Outcomes and concordance.
Djaileb A, Lavallee E, Parker M, Cayer M, Desautels F, de Grandmont M
Front Immunol. 2023; 13:1052424.
PMID: 36741379
PMC: 9895839.
DOI: 10.3389/fimmu.2022.1052424.
A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2.
Chaube U, Patel B, Bhatt H
3 Biotech. 2022; 13(1):12.
PMID: 36532857
PMC: 9755803.
DOI: 10.1007/s13205-022-03430-w.
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.
Valenzuela-Fernandez A, Cabrera-Rodriguez R, Ciuffreda L, Perez-Yanes S, Estevez-Herrera J, Gonzalez-Montelongo R
Front Bioeng Biotechnol. 2022; 10:1052436.
PMID: 36507266
PMC: 9732709.
DOI: 10.3389/fbioe.2022.1052436.
Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
Toomer G, Burns W, Garcia L, Henry G, Biancofiori A, George A
Viruses. 2022; 14(11).
PMID: 36423193
PMC: 9693146.
DOI: 10.3390/v14112584.
Candidate Multi-Epitope Vaccine against Corona B.1.617 Lineage: In Silico Approach.
Seadawy M, Zekri A, Saeed A, San E, Ageez A
Life (Basel). 2022; 12(11).
PMID: 36362871
PMC: 9694184.
DOI: 10.3390/life12111715.
Association of Clinical Features with Spike Glycoprotein Mutations in Iranian COVID-19 Patients.
Ahangarzadeh S, Yousefi A, Ranjbar M, Dabiri A, Zarepour A, Sadeghi M
J Clin Med. 2022; 11(21).
PMID: 36362544
PMC: 9654899.
DOI: 10.3390/jcm11216315.
SARS-COV-2 Notable Mutations and Variants: A Review Article.
Farhud D, Mojahed N
Iran J Public Health. 2022; 51(7):1494-1501.
PMID: 36248293
PMC: 9529736.
DOI: 10.18502/ijph.v51i7.10083.